345
Views
1
CrossRef citations to date
0
Altmetric
CASE REPORT

Encephalomyelomeningitis Caused by Balamuthia mandrillaris: A Case Report and Literature Review

, , , &
Pages 727-733 | Received 16 Dec 2022, Accepted 21 Jan 2023, Published online: 02 Feb 2023

References

  • Visvesvara GS, Martinez AJ, Schuster FL, et al. Leptomyxid ameba, a new agent of amebic meningoencephalitis in humans and animals. J Clin Microbiol. 1990;28:2750–2756. doi:10.1128/jcm.28.12.2750-2756.1990
  • Visvesvara GS, Moura H, Schuster FL. Pathogenic and opportunistic free-living amoebae: Acanthamoeba spp., Balamuthia mandrillaris, Naegleria fowleri, and Sappinia diploidea. FEMS Immunol Med Microbiol. 2007;50(1):1–26. doi:10.1111/j.1574-695X.2007.00232.x
  • Bhosale NK, Parija SC. Balamuthia mandrillaris: an opportunistic, free-living ameba - An updated review. Trop Parasitol. 2021;11(2):78–88. doi:10.4103/tp.tp_36_21
  • Deetz TR, Sawyer MH, Billman G, Schuster FL, Visvesvara GS. Successful treatment of Balamuthia amoebic encephalitis: presentation of 2 cases. Clin Infect Dis. 2003;37(10):1304–1312. doi:10.1086/379020
  • Siddiqui R, Khan A. Current treatment options of Balamuthia mandrillaris: a patent overview. Pharm Pat Anal. 2020;9(4):121–123. doi:10.4155/ppa-2020-0016
  • Kum SJ, Lee HW, Jung HR, et al. Amoebic encephalitis caused by Balamuthia mandrillaris. J Pathol Transl Med. 2019;53(5):327–331. doi:10.4132/jptm.2019.05.14
  • Baquero RA, Reyes-Batlle M, Nicola GG, et al. Presence of potentially pathogenic free-living amoebae strains from well water samples in Guinea-Bissau. Pathog Glob Health. 2014;108(4):206–211. doi:10.1179/2047773214Y.0000000143
  • Dunnebacke TH, Schuster FL, Yagi S, et al. Balamuthia mandrillaris from soil samples. Microbiology. 2004;150(Pt 9):2837–2842. doi:10.1099/mic.0.27218-0
  • Niyyati M, Karamati SA, Lorenzo MJ, et al. Isolation of Balamuthia mandrillaris from soil samples in North-Western Iran. Parasitol Res. 2016;115(2):541–545. doi:10.1007/s00436-015-4770-y
  • Bravo F, Sanchez MR. New and re-emerging cutaneous infectious diseases in Latin America and other geographic areas. Dermatol Clinics. 2003;21(4):655–668. doi:10.1016/S0733-8635(03)00090-1
  • Farnon EC, Kokko KE, Budge PJ, et al. Transmission of Balamuthia mandrillaris by Organ Transplantation. Clin Infect Dis. 2016;63(7):878–888. doi:10.1093/cid/ciw422
  • Kiderlen AF, Laube U. Balamuthia mandrillaris, an opportunistic agent of granulomatous amebic encephalitis, infects the brain via the olfactory nerve pathway. Parasitol Res. 2004;94(1):49–52. doi:10.1007/s00436-004-1163-z
  • Kiderlen AF, Laube U, Radam E, Tata PS. Oral infection of immunocompetent and immunodeficient mice with Balamuthia mandrillaris amebae. Parasitol Res. 2007;100(4):775–782. doi:10.1007/s00436-006-0334-5
  • Cope JR, Landa J, Nethercut H, et al. The epidemiology and clinical features of Balamuthia mandrillaris disease in the United States, 1974–2016. J Clin Microbiol. 2019;68(11):1815–1822.
  • Martinez AJ, Visvesvara GS. Balamuthia mandrillaris infection. J Med Microbiol. 2001;50(3):205–207. doi:10.1099/0022-1317-50-3-205
  • Matin A, Stins M, Kim KS, Khan NA. Balamuthia mandrillaris exhibits metalloprotease activities. FEMS Immunol Med Microbiol. 2006;47(1):83–91. doi:10.1111/j.1574-695X.2006.00065.x
  • Matin A, Nawaz S, Jung SY. Report: effect of macrophage alone or primed with cytokines on Balamuthia mandrillaris interactions with human brain microvascular endothelial cells in vitro. Pak J Pharm Sci. 2018;31(6):2553–2559.
  • Lorenzo-Morales J, Cabello-Vílchez AM, Martín-Navarro CM, Martínez-Carretero E, Piñero JE, Valladares B. Is Balamuthia mandrillaris a public health concern worldwide? Trends Parasitol. 2013;29(10):483–488. doi:10.1016/j.pt.2013.07.009
  • Wang L, Cheng W, Li B, et al. Balamuthia mandrillaris infection in China: a retrospective report of 28 cases. Emerg Microbes Infect. 2020;9(1):2348–2357. doi:10.1080/22221751.2020.1835447
  • Hu J, Zhang Y, Yu Y, et al. Encephalomyelitis caused by Balamuthia mandrillaris in a woman with breast cancer: a case report and review of the literature. Front Immunol. 2022;12:768065. doi:10.3389/fimmu.2021.768065
  • Cabello-Vílchez AM, Rodríguez-Zaragoza S, Piñero J, Valladares B, Lorenzo-Morales J. Balamuthia mandrillaris in South America: an emerging potential hidden pathogen in Perú. Exp Parasitol. 2014;145:S10–S19. doi:10.1016/j.exppara.2014.05.007
  • Bravo FG, Cabrera J, Gottuzo E, Visvesvara GS. Cutaneous manifestations of infection by free-living amebas. Trop Dermatol. 2006;50:49–55.
  • Yang Y, Hu X, Min L, et al. Balamuthia mandrillaris-related primary amoebic encephalitis in China diagnosed by next generation sequencing and a review of the literature. Lab Med. 2020;51(2):e20–e26. doi:10.1093/labmed/lmz079
  • Healy JF. Balamuthia amebic encephalitis: radiographic and pathologic findings. AJNR Am J Neuroradiol. 2002;23(3):486–489.
  • Duke BJ, Tyson RW, DeBiasi R, Freeman JE, Winston KR. Balamuthia mandrillaris meningoencephalitis presenting with acute hydrocephalus. Pediatr Neurosurg. 1997;26(2):107–111. doi:10.1159/000121172
  • Ong TYY, Khan NA, Siddiqui R, Kraft CS. Brain-eating amoebae: predilection sites in the brain and disease outcome. J Clin Microbiol. 2017;55(7):1989–1997. doi:10.1128/JCM.02300-16
  • Detering H, Aebischer T, Dabrowski PW, et al. First draft genome sequence of Balamuthia mandrillaris, the causative agent of amoebic encephalitis. Genome Announc. 2015;3(5):e01013–e01015. doi:10.1128/genomeA.01013-15
  • Armangue T, Spatola M, Vlagea A, et al. Spanish Herpes Simplex Encephalitis Study G Frequency, symptoms, risk factors, and outcomes of autoimmune encephalitis after herpes simplex encephalitis: a prospective observational study and retrospective analysis. Lancet Neurol. 2018;17(9):760–772. doi:10.1016/S1474-4422(18)30244-8
  • Shehab KW, Aboul-Nasr K, Elliott SP. Balamuthia mandrillaris granulomatous amebic encephalitis with renal dissemination in a previously healthy child: case report and review of the pediatric literature. J Pediatr Infect Dis Soc. 2018;7(3):e163–e168. doi:10.1093/jpids/pix089
  • Seidel JS, Harmatz P, Visvesvara GS, Cohen A, Edwards J, Turner J. Successful treatment of primary amebic meningoencephalitis. N Engl J Med. 1982;306(6):346–348. doi:10.1056/NEJM198202113060607
  • Schuster FL, Visvesvara GS. Axenic growth and drug sensitivity studies of Balamuthia mandrillaris, an agent of amebic meningoencephalitis in humans and other animals. J Clin Microbiol. 1996;34(2):385–388. doi:10.1128/jcm.34.2.385-388.1996
  • Rice CA, Colon BL, Chen E, Hull MV, Kyle DE. Discovery of repurposing drug candidates for the treatment of diseases caused by pathogenic free-living amoebae. PLoS Negl Trop Dis. 2020;14(9):e0008353. doi:10.1371/journal.pntd.0008353
  • Anwar A, Mungroo MR, Khan S, et al. Novel azoles as antiparasitic remedies against brain-eating amoebae. Antibiotics. 2020;9(4):188. doi:10.3390/antibiotics9040188
  • Siddiqui R, Mungroo MR, Anuar TS, et al. Antiamoebic properties of laboratory and clinically used drugs against Naegleria fowleri and balamuthia mandrillaris. Antibiotics. 2022;11(6):749. doi:10.3390/antibiotics11060749